Giorgio Walter Canonica

Giorgio Walter Canonica Giorgio Walter Canonica (Born October 25, 1947) is an Italian allergist, pulmonologist and professor of Respiratory Medicine at Humanitas University, Milan, Italy and Director ''Personalized Medicine Asthma & Allergy Center'' at Humanitas Research Hospital IRCCS-Milano Italy since December 2016. He is known for his research work related to innovative treatment strategies for allergic diseases which includes biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT). He served as President of several International or national Allergy and Respiratory Scientific Societies. Provided by Wikipedia
Showing 1 - 20 results of 112 for search 'Giorgio Walter Canonica', query time: 0.20s Refine Results
  1. 1
    History of the World Allergy Organization: Innovation in Continuity 2008-2009

    History of the World Allergy Organization: Innovation in Continuity 2008-2009 by Giorgio Walter Canonica, MD

    Published 2011-01-01
    Get full text
    Article
  2. 2
    Worldwide differences on the concept of control of asthma

    Worldwide differences on the concept of control of asthma by Fulvio Braido, Giorgio Walter Canonica

    Published 2008-02-01
    Get full text
    Article
  3. 3
    Biomarker relatability in the International Severe Asthma Network

    Biomarker relatability in the International Severe Asthma Network by David Price, Giorgio Walter Canonica

    Published 2020-08-01
    Get full text
    Article
  4. 4
    Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma

    Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma by Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, Francesca Puggioni, Giovanni Passalacqua, Giorgio Walter Canonica, Giorgio Walter Canonica

    Published 2017-08-01
    Get full text
    Article
  5. 5
    ''United Airways Disease'' and Phenotypic Peculiarities of Respiratory Allergy in Immigrants

    ''United Airways Disease'' and Phenotypic Peculiarities of Respiratory Allergy in Immigrants by Carlo Lombardi, Giovanni Passalaqua, Giorgio Walter Canonica

    Published 2009-01-01
    Get full text
    Article
  6. 6
    Is Sublingual Immunotherapy the Final Answer? Implications for the Allergist

    Is Sublingual Immunotherapy the Final Answer? Implications for the Allergist by Giorgio Walter Canonica, MD, Giovanni Passalacqua, MD

    Published 2008-01-01
    Get full text
    Article
  7. 7
    Sublingual Immunotherapy: Recent Advances

    Sublingual Immunotherapy: Recent Advances by Enrico Compalati, Fulvio Braido, Giorgio Walter Canonica

    Published 2013-01-01
    Get full text
    Article
  8. 8
    Patient's Adherence and Compliance and Quality of Life During/After VIT

    Patient's Adherence and Compliance and Quality of Life During/After VIT by Cristoforo Incorvaia, Enrico Heffler, Enrico Heffler, Silvia Peveri, Francesco Pucciarini, Giorgio Walter Canonica, Giorgio Walter Canonica, Erminia Ridolo

    Published 2022-06-01
    Get full text
    Article
  9. 9
    Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?

    Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ? by Cristoforo Incorvaia, Erminia Ridolo, Marina Mauro, Francesco Pucciarini, Enrico Heffler, Enrico Heffler, Giorgio Walter Canonica, Giorgio Walter Canonica

    Published 2022-02-01
    Get full text
    Article
  10. 10
    Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

    Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis by Enrico Heffler, Fabiana Saccheri, Marta Bartezaghi, Giorgio Walter Canonica

    Published 2020-06-01
    Get full text
    Article
  11. 11
    Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

    Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial by Andrzej Bożek, Krzysztof Kołodziejczyk, Renata Kozłowska, Giorgio Walter Canonica

    Published 2017-12-01
    Get full text
    Article
  12. 12
    Type 2 immunity in asthma

    Type 2 immunity in asthma by Marco Caminati, Duy Le Pham, Diego Bagnasco, Giorgio Walter Canonica

    Published 2018-06-01
    Get full text
    Article
  13. 13
    Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper

    Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper by Giovanni. Passalacqua, MD, Enrico. Compalati, MD, Giorgio Walter Canonica, MD

    Published 2010-01-01
    Get full text
    Article
  14. 14
    Adding a biologic to allergen immunotherapy increases treatment efficacy

    Adding a biologic to allergen immunotherapy increases treatment efficacy by Andrzej Bożek, Andreas Fischer, Agnieszka Bogacz-Piaseczynska, Giorgio Walter Canonica

    Published 2023-04-01
    Get full text
    Article
  15. 15
    Personalized medicine and allergen immunotherapy: the beginning of a new era?

    Personalized medicine and allergen immunotherapy: the beginning of a new era? by Cristoforo Incorvaia, Erminia Ridolo, Diego Bagnasco, Silvia Scurati, Giorgio Walter Canonica

    Published 2021-07-01
    Get full text
    Article
  16. 16
    Clinical relevance of pre‐ and coseasonal sublingual immunotherapy with a 300 index of reactivity 5‐grass SLIT tablet in allergic rhinoconjunctivitis

    Clinical relevance of pre‐ and coseasonal sublingual immunotherapy with a 300 index of reactivity 5‐grass SLIT tablet in allergic rhinoconjunctivitis by Oliver Pfaar, Ulrich Wahn, Giorgio Walter Canonica, Farah Bahbah, Philippe Devillier

    Published 2023-12-01
    Get full text
    Article
  17. 17
    Is allergic sensitization relevant in severe asthma? Which allergens may be culprits?

    Is allergic sensitization relevant in severe asthma? Which allergens may be culprits? by Carlo Lombardi, Eleonora Savi, Erminia Ridolo, Giovanni Passalacqua, Giorgio Walter Canonica

    Published 2017-01-01
    Get full text
    Article
  18. 18
    Interleukin-5 in the Pathophysiology of Severe Asthma

    Interleukin-5 in the Pathophysiology of Severe Asthma by Corrado Pelaia, Giovanni Paoletti, Giovanni Paoletti, Francesca Puggioni, Francesca Puggioni, Francesca Racca, Francesca Racca, Girolamo Pelaia, Giorgio Walter Canonica, Giorgio Walter Canonica, Enrico Heffler, Enrico Heffler

    Published 2019-12-01
    Get full text
    Article
  19. 19
    The Use of Emerging Technologies in Allergen Immunotherapy Management

    The Use of Emerging Technologies in Allergen Immunotherapy Management by Giovanni Melioli, Anna Maria Riccio, Sabina Ledda, Giovanni Passalacqua, Giorgio Walter Canonica

    Published 2017-08-01
    Get full text
    Article
  20. 20
    Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® In the Management of Asthma) study

    Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® In the Management of Asthma) st... by Delia Colombo, Emanuela Zagni, Fabio Ferri, Giorgio Walter Canonica, the PROXIMA study centers

    Published 2019-11-01
    Get full text
    Article

Search Tools: